Alhassane Diallo - Concepedia

Author

Alhassane Diallo

Also Known As

A. Diallo, Alhassane 1 Diallo, Alhassane Diallo, DIALLO, ALhassane, Diallo Alhassane, Diallo, Alhassane, Diallo,Alhassane, Seydouba Conte, Sonia Molho

Publications

Citations

H-Index

Concepts

All Affiliations

Inserm Sorbonne Université Assistance Publique – Hôpitaux de Paris Institut Pierre Louis d‘Épidémiologie et de Santé Publique German Center for Neurodegenerative Diseases

About

Alhassane Diallo is an author at Inserm specializing in medicine, neuropathology, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	511
2	Neurology	3	3	468
3	Neuroscience	2	2	406
4	Pharmacology	2	2	43
5	Radiation Medicine	1	1	30

Alhassane Diallo

Publications

769

Citations

H-Index

Page 1

	Year	Citations
Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study Heike Jacobi, Sophie Tézenas du Montcel, Peter Bauer, The Lancet Neurology Longitudinal Cohort StudyNeurological DisorderLong-term Disease ProgressionNeurologyNeuroscience	2015	286
Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study Alhassane Diallo, Heike Jacobi, Arron Cook, The Lancet Neurology Longitudinal Cohort StudyNeurologyNeuroscienceNeuropathologyMedicine	2018	120
Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias Heike Jacobi, Sophie Tézenas du Montcel, Peter Bauer, Journal of Neurology NeurorehabilitationNeurological FunctioningLong-term EvolutionNeurological DisorderNeuroimaging	2018	62
Development of <scp>SARA<sup>home</sup></scp>, a New Video‐Based Tool for the Assessment of Ataxia at Home Marcus Grobe‐Einsler, Arian Taheri Amin, Jennifer Faber, Movement Disorders	2021	61
<i>PIK3CA</i> Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients Anne de la Rochefordière, Maud Kamal, Anne Floquet, Clinical Cancer Research	2015	52
Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma Sophie Piperno‐Neumann, Alhassane Diallo, Marie-Christine Étienne-Grimaldi, The Oncologist	2016	44
Body Mass Index Decline Is Related to Spinocerebellar Ataxia Disease Progression Alhassane Diallo, Heike Jacobi, Tanja Schmitz‐Hübsch, Movement Disorders Clinical Practice	2017	35
Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial Louis Bazire, Isabelle Fromantin, Alhassane Diallo, Radiotherapy and Oncology Radio-induced Skin ToxicityRadiation MedicineMedicineRadiation ExposureRadiopharmaceutical Therapy	2015	30
Low cancer prevalence in polyglutamine expansion diseases Giulia Coarelli, Alhassane Diallo, Morgane Sonia Thion, Neurology	2017	30
Prediction of Survival With Long‐Term Disease Progression in Most Common Spinocerebellar Ataxia Alhassane Diallo, Heike Jacobi, Arron Cook, Movement Disorders	2019	18

Page 1